- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1950
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia ; volume:78 ; number:18 ; day:3 ; month:12 ; year:2018 ; pages:1903-1910 ; date:12.2018
Drugs ; 78, Heft 18 (3.12.2018), 1903-1910, 12.2018
- Urheber
-
Blair, Hannah A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40265-018-1022-3
- URN
-
urn:nbn:de:101:1-2019013120275174197107
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Blair, Hannah A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction to: Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia
Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia
Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
Homoharringtonine enhances cytarabine-induced apoptosis in acute myeloid leukaemia by regulating the p38 MAPK/H2AX/Mcl-1 axis
Identification of CDX2 targets in acute myeloid leukaemia
Decreased MMP1 gene expression in acute myeloid leukaemia
A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
Single cell analysis of clonal architecture in acute myeloid leukaemia
Correction to: Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia
Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia
Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
Homoharringtonine enhances cytarabine-induced apoptosis in acute myeloid leukaemia by regulating the p38 MAPK/H2AX/Mcl-1 axis
Identification of CDX2 targets in acute myeloid leukaemia
Decreased MMP1 gene expression in acute myeloid leukaemia
A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
Single cell analysis of clonal architecture in acute myeloid leukaemia
Correction to: Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia
Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia
Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
Homoharringtonine enhances cytarabine-induced apoptosis in acute myeloid leukaemia by regulating the p38 MAPK/H2AX/Mcl-1 axis
Identification of CDX2 targets in acute myeloid leukaemia
Decreased MMP1 gene expression in acute myeloid leukaemia
A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia